Literature DB >> 23932451

Synthesis and biological evaluation of berberine-thiophenyl hybrids as multi-functional agents: Inhibition of acetylcholinesterase, butyrylcholinesterase, and Aβ aggregation and antioxidant activity.

Tao Su1, Shishun Xie, Hui Wei, Jun Yan, Ling Huang, Xingshu Li.   

Abstract

A series of berberine-thiophenyl hybrids were designed, synthesised, and evaluated as inhibitors of acetylcholinesterase (AChE), butyrylcholinesterase (BuChE) and β-amyloid (Aβ) aggregation and as antioxidants. Among these hybrids, compounds 4f and 4i, berberine linked with o-methylthiophenyl and o-chlorothiophenyl by a 2-carbon spacer, were observed to be potent inhibitors of AChE, with IC50 values of 0.077 and 0.042 μM, respectively. Of the tested compounds, 4i was also the most potent inhibitor of BuChE, with an IC50 value of 0.662 μM. Kinetic studies and molecular modelling simulations of the AChE-inhibitor complex indicated that a mixed-competitive binding mode existed for these berberine derivatives. The biological studies also demonstrated that these hybrids displayed interesting activities, including Aβ aggregation inhibition and antioxidant properties.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Antioxidants; Inhibitors of AChE; berberine–thiophenyl hybrids; β-Amyloid aggregation

Mesh:

Substances:

Year:  2013        PMID: 23932451     DOI: 10.1016/j.bmc.2013.07.011

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  5 in total

1.  Investigation of naphthofuran moiety as potential dual inhibitor against BACE-1 and GSK-3β: molecular dynamics simulations, binding energy, and network analysis to identify first-in-class dual inhibitors against Alzheimer's disease.

Authors:  Akhil Kumar; Gaurava Srivastava; Swati Srivastava; Seema Verma; Arvind S Negi; Ashok Sharma
Journal:  J Mol Model       Date:  2017-07-24       Impact factor: 1.810

Review 2.  Bioactive Compounds and Their Derivatives: An Insight into Prospective Phytotherapeutic Approach against Alzheimer's Disease.

Authors:  Fahadul Islam; Jannatul Fardous Khadija; Md Harun-Or-Rashid; Md Saidur Rahaman; Mohamed H Nafady; Md Rezaul Islam; Aklima Akter; Talha Bin Emran; Polrat Wilairatana; Mohammad S Mubarak
Journal:  Oxid Med Cell Longev       Date:  2022-04-11       Impact factor: 7.310

Review 3.  Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease.

Authors:  Natalia Guzior; Anna Wieckowska; Dawid Panek; Barbara Malawska
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

4.  Discovery of novel PDE9 inhibitors capable of inhibiting Aβ aggregation as potential candidates for the treatment of Alzheimer's disease.

Authors:  Tao Su; Tianhua Zhang; Shishun Xie; Jun Yan; Yinuo Wu; Xingshu Li; Ling Huang; Hai-Bin Luo
Journal:  Sci Rep       Date:  2016-02-25       Impact factor: 4.379

5.  Anti-Acetylcholinesterase Activities of Mono-Herbal Extracts and Exhibited Synergistic Effects of the Phytoconstituents: A Biochemical and Computational Study.

Authors:  Acharya Balkrishna; Subarna Pokhrel; Meenu Tomer; Sudeep Verma; Ajay Kumar; Pradeep Nain; Abhishek Gupta; Anurag Varshney
Journal:  Molecules       Date:  2019-11-18       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.